Similarly, the serum levels of CEA (1.865 [1.255, 3.200] ng/mL) and CA15-3 (11.850 [8.225, 19.125] U/mL) were also considerably higher in breast cancer patients group (P < .001; Fig. 1C and D). The gene discussed is CEACAM5; the disease is breast carcinoma.